| Quarter | Score |
|---|---|
| 2019-Q1 | 52.0 |
| 2019-Q3 | 45.2 |
| 2019-Q4 | 46.4 |
| 2020-Q2 | 48.3 |
| 2022-Q1 | 61.8 |
| 2022-Q2 | 50.7 |
| 2022-Q3 | 51.2 |
| 2022-Q4 | 53.8 |
| 2023-Q1 | 50.2 |
| 2023-Q2 | 49.0 |
| 2023-Q3 | 54.3 |
| 2023-Q4 | 55.2 |
| 2024-Q1 | 62.4 |
| 2024-Q2 | 66.5 |
| 2024-Q3 | 83.9 |
| 2024-Q4 | 64.6 |
| 2025-Q1 | 86.0 |
| 2025-Q2 | 85.8 |
| 2025-Q3 | 85.9 |
| 2025-Q4 | 85.9 |
| 2026-Q1 | 85.6 |
| 2026-Q2 | 84.6 |
High consensus with active accumulation at an attractive valuation
Within 4.1% of funds' estimated purchase price
2 of 18 tracked funds hold BHF. Avg conviction: 2.3%. Net adding. First tracked at $51.51 (current +4.1% vs tracked).
Greenlight Capital has 4.6% in this stock
Benchmark comparison unavailable
Prices are approximate, based on 13F reported values (position value / shares), not actual cost basis. Data covers 17 tracked value-oriented funds. Holdings are reported quarterly with a ~45-day lag. Stock splits may affect share count comparisons. Returns are not annualized.
| Fund | % of Portfolio | Action |
|---|---|---|
| Greenlight Capital | 4.6% | Hold |
| Citadel Advisors | 0.0% | Add |